Professor Kausik Ray
Our selection of trials, registry data and guideline updates from the 2014 European Society of Cardiology (ESC) Congress. Professor Kausik Ray puts the key studies into clinical perspective, and explains why the extent – not the means – of LDL cholesterol lowering is key in the prevention of CVD.
Professor Jane Armitage, Professor Gerald Watts
Highlights of studies presented at the 2014 European Atherosclerosis Society Congress. Professor Jane Armitage discusses new lipid treatments for managing CV risk, and existing therapies to lower LDL cholesterol. Professor Gerald Watts discuss the International Familial Hypercholesterolaemia Foundation guidelines.
Dr Henry Oluwasefunmi Savage
Highlights from the 2013 European Society of Cardiology (ESC) Congress. Dr Henry Oluwasefunmi Savage discusses the GARFIELD registry, and the SERVE-HF study.
Dr Henry Oluwasefunmi Savage, Royal Brompton Hospital, London, discusses:
Dr Terry McCormack
Highlights from the 2013 European Society of Cardiology (ESC) Congress. Dr Terry McCormack discusses the EXAMINE and SAVOR-TIMI 53 studies, edoxaban, the RE-ALIGN study and the EHRA practical guide to the use of the new oral anticoagulants.
Dr Terry McCormack, Whitby GP and BJC editor, discusses:
Dr Paul Kalra
Highlights from the 2013 European Society of Cardiology (ESC) Congress. Dr Paul Kalra discusses the ESC Guidelines on stable coronary artery disease, the ECHO-CRT trial, and primary PCI in STEMI patients.
Dr Paul Kalra, Portsmouth Hospitals NHS Trust, discusses:
Professor Keith Fox, Dr Sarah Jarvis
Highlights from the 2012 European Society of Cardiology (ESC) Congress. Professor Keith Fox highlights exciting developments for treatment in AF. Dr Sarah Jarvis provides a primary care take on the latest guidelines for heart failure.